Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of the year 2025
26 Aug, 2019

According to Renub Research market research report “Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable” Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of the year 2025. Next Generation Sequencing (NGS) has revolutionized genomic research and molecular biology. NGS has made the sequencing of genomes rapid and cost-effective, and with this deep and parallel sequencing technology billions of DNA strands can be sequenced efficiently. Analysis of DNA protein interactions, sequencing of whole genomes, various interventions such as drug discovery, oncology, understanding reproductive health, biomarker studies, and personalized genomics can be performed with NGS.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=next-generation-sequencing-market-p.php

Sequencing products of the next generation include instruments, consumables, and software. The Sequencing product segment of the next generation is increasing some main factors such as new product launches, elevated consumables use, and easy accessibility. Next-generation sequencing services are also expected to grow due to the need for new platforms for advances in bioinformatics and the rapid interpretation of DNA data pave the way for start-ups, particularly for sequencing services of the next generation.  The price of sequencing has decreased over the years, with the introduction of next-generation sequencing.  This has a positive impact on this segment's development.

Besides, the implementation of sequencing-based testing of the next generation is growing worldwide. This is anticipated to drive the segment's development over the projected period, coupled with appealing healthcare reimbursement policies.

NGS platforms are helpful in diagnosis and analysis of rare diseases as well as prenatal testing and identifying therapeutic with the advancement in bioinformatics. NGS methodologies will be in high demand in genomics research, precision treatment of various diseases, clinical diagnosis, and personalized medicine. Technical progress in cloud computing and data integration is also boosting the market of Next Generation Sequencing.

Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=next-generation-sequencing-market-p.php

Market Summary:

• By Type of Test: Target Re-Sequencing and Whole Exome sequencing are having the major market share in Clinical Next Generation Sequencing Market. The research report covers market and market share of the following type of test: Targeted Re-sequencing (TPS/WES), Whole Genome Sequencing, RNA-Sequencing, ChIP-Sequencing, Methyl-Sequencing, and De Novo Sequencing.
• By Disease: Oncology Test Market has a significant market share in Clinical Next Generation Sequencing Market. Market and market share of Oncology (Cancer), Rare Disease Diagnostics, Reproductive Health, Cardiovascular, Metabolic Immune (Diagnostic), and other diseases are given in the report.
• By NGS Informatics Type: Market and market share of Biological Interpretation and Reporting Tools, NGS Informatics Services, Storage, Computing, Primary and Secondary Data Analysis Tools and LIMS Laboratory Information Management System are coved in the report.
• By End-User: Academic Research, Healthcare, Biotech / Pharma, Government, and other end users are covered with market and market share in NGS market research report.
• By Companies: Overview, recent development, and strategy of the following companies are given in the report:  Illumina, Pacific Biosciences, Thermo Fisher Scientific, Roche, Oxford Nanopore Technologies.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com

Key Topics Covered :

1.    Introduction
2.    Research Methodology
3.    Executive Summary
4.    Market Dynamics

4.1    Growth Driver
4.2    Challenges

5.    Global Next Generation Sequencing (NGS) Market

6.    Market Share – Global Next Generation Sequencing (NGS) 

6.1    By End-User
6.2    By Type of Test
6.3    By Disease 
6.4    By NGS Informatics Type

7.    End-User – Global Next Generation Sequencing Market 

7.1    Academic Research    
7.2    Healthcare    
7.3    Biotech/Pharma    
7.4    Government    
7.5    Others

8.    Type of Test – Global Clinical Next Generation Sequencing Market 

8.1    Targeted Re-sequencing (TPS/WES)
8.2    RNA-Sequencing
8.3    Whole Genome Sequencing
8.4    ChIP-Sequencing
8.5    De Novo Sequencing
8.6    Methyl-Sequencing

9.    Disease – Global Next Generation Sequencing Test Market 

9.1    Reproductive Health
9.2    Rare Disease Diagnostics
9.3    Oncology (Cancer)
9.4    Metabolic Immune (Diagnostic)
9.5    Cardiovascular
9.6    Others

10.    Platform – Global Next Generation Sequencing Market 
11.    Consumable – Global Next Generation Sequencing Market

12.    Informatics – Global Next Generation Sequencing Market

12.1    NGS Informatics Services
12.2    Primary and Secondary Data Analysis Tools
12.3    Storage
12.4    Computing
12.5    Biological Interpretation and Reporting Tools
12.6    LIMS (Laboratory Information Management System)    

13.    Reimbursement

14.    Company Analysis

14.1    Illumina
14.2    Thermo Fisher Scientific
14.3    Pacific Biosciences
14.4    Oxford Nanopore Technologies
14.5    Roche

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research